Employer record no. 14233
Dyne Therapeutics, Inc.
US DOL LCA disclosure data, FY2021 to FY2026
Total LCA filings
28
Certified
27
Denied
0
FY2025 filings
6
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#1,079 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2021 | 6 | 6 | 0 | $98,850 | $83,855 |
| FY2022 | 3 | 3 | 0 | $97,333 | $75,858 |
| FY2023 | 1 | 1 | 0 | $175,000 | $170,020 |
| FY2024 | 7 | 6 | 0 | $171,521 | $135,684 |
| FY2025 | 6 | 6 | 0 | $181,105 | $133,422 |
| FY2026 * | 5 | 5 | 0 | $182,602 | $127,609 |
What they file for
- associate director, clinical operations study lead$185,6252
- associate director, statistical programming$207,5002
- director, analytical development/quality control (qc)$211,7652
- director, drug safety & pharmacovigilance scientist$237,5002
- research associate, platform development$81,0002
- associate director, analytical development/qc$175,0001
- manager, analytical development and quality control$130,0001
- research associate$75,0001
Where
- waltham, ma28
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Dyne Therapeutics, Inc. and any other employer they watch.
Certification rate 96.4%How these numbers are computed